Document is current

Any future updates will be listed below

Integrative network pharmacology and in vitro validation reveal the mechanisms by which Apigenin reverses MET-TKI resistance in non-small cell lung cancer

Crossref DOI link: https://doi.org/10.1007/s12672-026-04837-0

Published Online: 2026-03-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark